← Leaderboards
Matthew H Wilson
Veterans Health Administration
$7,020,154
Attributed
$7,690,084
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,690,084 · 5
VA$0 · 2
By mechanism
R01$6,692,994 · 4
P30$997,090 · 1
I01$0 · 2
Top collaborators
- Aravind Asokan1 shared
- Shuvo Roy1 shared
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyAffectIn VivoInnovationMediatingCellsMouse ModelKidney DiseasesGene TransferAnimalsEngineeringIn VitroAnimal ModelSiteGeneticProteinsChronic Kidney FailureMorbidity - Disease RateGrantGene DeliveryTechnologyExperimental DesignsChronicResponse
Grant awards (33)
Kidney targeted AAV for gene therapy$859,980
R01 · FY2025 · DK · contact PI
Next generation transposon vectors for genome engineering$491,492
R01 · FY2025 · EB · contact PI
Beyond Urea Kinetics: Balancing Tradeoffs in Dialyzer Design for the Next 50 Years$479,880
R01 · FY2025 · DK · contact PI
Genome engineering therapeutics for cystinuria and its metabolic consequences.$0
I01 · FY2025 · VA · contact PI
Next generation transposon vectors for genome engineering$481,663
R01 · FY2024 · EB · contact PI
Genome engineering therapeutics for cystinuria and its metabolic consequences.$0
I01 · FY2024 · VA · contact PI
Next generation transposon vectors for genome engineering$491,492
R01 · FY2023 · EB · contact PI
Genome engineering therapeutics for cystinuria and its metabolic consequences.$0
I01 · FY2023 · VA · contact PI
Next generation transposon vectors for genome engineering$525,492
R01 · FY2022 · EB · contact PI
Novel cell therapy for sustained therapeutic protein delivery in vivo$416,707
R01 · FY2022 · DK · contact PI
Novel cell therapy for sustained therapeutic protein delivery in vivo$416,707
R01 · FY2021 · DK · contact PI
Pilot and Feasibility Program$199,418
P30 · FY2021 · DK · contact PI
Metabolic consequences of cystinuria and genome engineering therapeutics$0
I01 · FY2021 · VA · contact PI
Novel cell therapy for sustained therapeutic protein delivery in vivo$416,708
R01 · FY2020 · DK · contact PI
Pilot and Feasibility Program$199,418
P30 · FY2020 · DK · contact PI
Metabolic consequences of cystinuria and genome engineering therapeutics$0
I01 · FY2020 · VA · contact PI
Novel cell therapy for sustained therapeutic protein delivery in vivo$416,707
R01 · FY2019 · DK · contact PI
Pilot and Feasibility Program$199,418
P30 · FY2019 · DK · contact PI
Metabolic consequences of cystinuria and genome engineering therapeutics$0
I01 · FY2019 · VA · contact PI
Pilot and Feasibility Program$199,418
P30 · FY2018 · DK · contact PI
Metabolic consequences of cystinuria and genome engineering therapeutics$0
I01 · FY2018 · VA · contact PI
Pilot and Feasibility Program$199,418
P30 · FY2017 · DK · contact PI
Kidney specific site-directed integration for cystinuria$0
I01 · FY2017 · VA · contact PI
Novel cell therapy for anemia of CKD$343,650
R01 · FY2016 · DK · contact PI
Kidney specific site-directed integration for cystinuria$0
I01 · FY2016 · VA · contact PI
Novel cell therapy for anemia of CKD$230,834
R01 · FY2015 · DK · contact PI
Novel cell therapy for anemia of CKD$111,346
R01 · FY2015 · DK · contact PI
Kidney specific site-directed integration for cystinuria$0
I01 · FY2015 · VA · contact PI
Novel cell therapy for anemia of CKD$341,475
R01 · FY2014 · DK · contact PI
Kidney specific site-directed integration for cystinuria$0
I01 · FY2014 · VA · contact PI
Novel cell therapy for anemia of CKD$327,204
R01 · FY2013 · DK · contact PI
Novel cell therapy for anemia of CKD$1,269
R01 · FY2013 · DK · contact PI
Novel cell therapy for anemia of CKD$340,388
R01 · FY2012 · DK · contact PI